TCL Archive NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics March 26, 1999
TCL Archive Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected October 1, 1976
TCL Archive In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs January 17, 1992
TCL Archive President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20% February 2, 1990
TCL Archive Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds May 23, 1997